Skip to main content
. 2023 Jul 12;12(4):71. doi: 10.21037/atm-23-1569

Table 3. Summary of recent and/or popular total ankle replacements and their outcomes.

Implant Study No. of implants Follow-up (years), median (IQR) Survivorship Reoperation rate
Agility Knecht, 2004 (74) 132 9.0 (7.0 to 16) 89.00% Not recorded
Raikin, 2017 (22) 115 9.1 (4.0 to 14) 78.20% Not recorded
Cadence Fram, 2022 (75) 58 Minimum 2 94.80% 20.70%
Kim, 2023 (30) 48 2.8 (2.0 to 4.2) 93.80% 6.30%
HINTEGRA Yang, 2019 (76) 210 6.4 (2.0 to 13.4) 91.70% 9.00%
Yoon, 2022 (77) 151 11.3 (10 to 17) 93.50% 22.50%
INBONE I Adams, 2014 (17) 194 3.7 (2.2 to 5.5) 89.00% 25%
Harston, 2017 (78) 149 5.9 (4.0 to 9.4) 90.60% 13.40%
INBONE II Lewis, 2015 (79) 56 2.1 (1.3 to 2.9) 97.40% 15.90%
Gagne, 2022 (20) 51 6.4 (5.0 to 9.0) 98.00% 7.80%
INFINITY Saito, 2018 (33) 64 2.0 (1.5 to 3.3) 95.30% 17.10%
Cody, 2019 (80) 159 1.6 (1.0 to 3.1) 90.00% Not recorded
Salto Talaris Stewart, 2017 (23) 106 6.8 (5.0 to 9.6) 95.80% 19.00%
Day, 2020 (22) 85 7.1 (5.0 to 12) 97.60% 21.20%
STAR Wood, 2003 (81) 143 7.3 (5.0 to 13.0) 80.30% Not recorded
Clough, 2019 (82) 87 15.8 (11.1 to 24.5) 76.16% Not recorded
Zimmer Barg, 2018 (83) 55 2.2 (1.9 to 2.6) 93.00% 18.20%
Maccario, 2022 (29) 86 5.4 (5.0 to 7.5) 97.70% Not recorded

IQR, interquartile range.